COVID-19 and Neoplasia: an epidemiological study of cases reported in Mato Grosso/COVID-19 e Neoplasia: um estudo epidemiologico dos casos notificados em Mato Grosso/COVID-19 y Neoplasia: un estudio epidemiologico de los casos notificados en Mato Grosso

This study aimed to analyze the reported cases of COVID-19 in patients with cancer comorbidity in Mato Grosso. A retrospective and descriptive epidemiological method was used, based on confirmed cases of COVID-19, between March 2020 and March 2022, in the State of Mato Grosso. The descriptive analysis of the data in simple and absolute frequencies was aided by the R software. A total of 727,943 cases of COVID-19 were reported, 0.17% of which had cancer comorbidity. Of these cases, the predominant ones were in the Baixada Cuiabana region (41.07%) and the profile was female (53.24%), age group 56-69 years (29.86%), brown race (52.20%), 0.03% hospitalized and clinical outcome recovered cases (72.78%). Cases of COVID-19 in cancer patients provide substantial insights into the interplay between these health conditions and the challenges they face. These cases highlight the vulnerability of individuals with cancer during the pandemic, due to the immunological suppression resulting from cancer and associated treatments, such as chemotherapy and radiotherapy, which increases the likelihood of serious complications resulting from COVID19. In addition, they highlight the need for preventive strategies and approaches specific to this population. Keywords: Neoplasms. COVID-19. Epidemiological Study. Collective Diseases. Este estudo objetivou analisar os casos notificados de COVID-19 em pacientes com comorbidade de cancer em Mato Grosso. Utilizou-se um metodo epidemiologico retrospectivo e descritivo, baseado nos casos confirmados de COVID-19, entre marco de 2020 e marco de 2022, do Estrado de Mato Grosso. A analise descritiva dos dados em frequencias simples e absoluta foram auxiliadas pelo software R. Foram notificados 727.943 casos de COVID-19, sendo 0,17% com comorbidade cancer. Destes casos, prevaleceram na regiao Baixada Cuiabana (41,07%) e perfil sexo feminino (53,24%), faixa etaria 56-69 anos (29,86%), raca parda (52,20%), 0,03% hospitalizados e desfecho clinico casos recuperados (72,78%). Os casos de COVID-19 em pacientes com cancer oferecem uma compreensao substancial sobre a interacao entre essas condicoes de saude e os desafios enfrentados. Esses casos destacam a vulnerabilidade dos individuos com cancer durante a pandemia, devido a supressao imunologica resultante do cancer e dos tratamentos associados, como quimioterapia e radioterapia, o que aumenta a probabilidade de complicacoes graves decorrentes da COVID19. Alem disso, ressaltam a necessidade de estr